SBIR Phase II: Tissue Engineered Cartilage for Drug Discovery

Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0422194
Agency Tracking Number: 0320087
Amount: $499,914.00
Phase: Phase II
Program: SBIR
Awards Year: 2004
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Articular Engineering, LLC
1818 Skokie Blvd. Suite 158, Northbrook, IL, 60062
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Brian Pfister
 PI
 (847) 498-9634
 kmasuda@articular.com
Business Contact
 Brian Pfister
Phone: (847) 498-9634
Email: bpfister@articular.com
Research Institution
N/A
Abstract
This Small Business Innovation Research Phase II project is to develop scale-up production technology to produce engineered cartilage for drug discovery using a proprietary Alginate Recovered Chondrocyte (ARC) method. This method stimulates adult human cartilage cells to form a cartilaginous tissue with proper compositional and functional properties. ARC cartilage tissue is expected to offer a cost-effective alternative to current culture systems and expensive animal studies while utilizing human tissue. The commercial application of this project will be in the area of drug discovery for cartilage-related problems such as rheumatoid arthritis.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government